Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test’s Potential to Expand the Clinical Use of Immunotherapy
May 26, 2022
Neuropathix, Inc. Receives Patent Grant from India for Its Novel Anti-Inflammatory Compounds
January 18, 2022
Related Post
-
-
Qualigen Therapeutics’ Pan-RAS Inhibitor Featured in Two Abstracts at American Society for Clinical Oncology (ASCO) 2022 Annual Meeting
May 26, 2022
-
Striving to Treat Inflammation Safely and More Effectively
May 25, 2022
-
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
May 25, 2022